Hartford Investment Management CO Concert Pharmaceuticals, Inc. Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019
SELL
$11.25 - $16.17 $162,247 - $233,203
-14,422 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$12.82 - $17.88 $12,332 - $17,200
-962 Reduced 6.25%
14,422 $214,000
Q2 2018

Jul 19, 2018
BUY
$16.83 - $21.66 $258,912 - $333,217
15,384 New
15,384 $259,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email